Rabilab-L Capsule SR
Marketer
Golden Square Lab Pvt Ltd
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Overview Rabilab-L Capsule SR
Gastro-intestinal medication, Relpax SR capsules, is a prescription drug indicated for treating gastroesophageal reflux disease (GERD), peptic ulcers, and irritable bowel syndrome (IBS). It functions by suppressing excessive stomach acid secretion and preventing its backflow into the esophagus. Relpax SR capsules are administered with or without food, following the physician's prescribed dosage and duration. Dosage is individualized based on your health status and response. Consistent use, as directed by your doctor, is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all concurrent medications, as interactions may occur. Commonly reported side effects include nausea, abdominal discomfort, diarrhea, gas, constipation, headache, fatigue, and influenza-like symptoms; most are transient and self-limiting. Report any concerning side effects promptly to your physician. Dizziness and somnolence are possible; avoid driving or tasks demanding alertness until the drug's effects are known. Alcohol consumption should be avoided due to potential additive drowsiness. Lifestyle adjustments, such as a high-fiber diet, avoidance of trigger foods, increased hydration, and regular physical activity, can enhance treatment outcomes. Prior to initiation, disclose any kidney or liver conditions, and inform your doctor if you are pregnant, considering pregnancy, or breastfeeding.
Primary Ingredients of Rabilab-L Capsule SR
The provided text is "undefined," therefore no rewriting is possible.
Uses of Rabilab-L Capsule SR
Managing gastroesophageal reflux disease (GERD) | Treating peptic ulcers | Addressing irritable bowel syndrome
Major Benefits of Rabilab-L Capsule SR:
Follow your physician's instructions precisely regarding dosage and treatment length for Rabilab-L SR Capsules. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Rabilab-L Capsule SR:
- Nausea
- Stomach pain
- Diarrhea
- Flatulence
- Constipation
- Headache
- Dizziness
- Weakness
- Sleepiness
- Flu-like symptoms
How to use Rabilab-L Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Rabilab-L SR Capsules. Ingest the capsule whole; avoid crushing, chewing, or breaking it. Administer on an empty stomach.
How Rabilab-L Capsule SR works:
Each Rabilab-L SR capsule contains a dual formulation of levosulpiride and rabeprazole.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Rabilab-L Capsule SR ingestion is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Rabilab-L Capsule SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Data on Rabilab-L Capsule SR use while breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by the side effects of Rabilab-L Capsule SR.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Rabilab-L Capsule SR's efficacy and safety in individuals with renal impairment. Physician consultation is advised. Preliminary findings, however, indicate that its use in such patients should be approached with prudence.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Rabilab-L Capsule SR. Dosage modification of Rabilab-L Capsule SR may be necessary; physician consultation is advised.
What if you forget to take Rabilab-L Capsule SR :
Should you forget a Rabilab-L Capsule SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabilab-L Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |


